1/3 L-WAVE ENT 19/2019 14 August 2019 Subject : Management’s Discussion and Analysis for the six-month period ending 30 June 2019 operating results that varied more than 20% compared to the same
. would like to inform the financial results for the second quarter of 2019. The Company and its subsidiary reported a net profit of THB 131. 25 million, comparing to a net profit of THB 126. 43 million in
August 28, 2019 Re: Clarification of the operating results of company and its subsidiaries for the year ended December 31, 2017 To: Boards and Managements The Stock Exchange of Thailand K.C. Property
1/4 August 28, 2019 Re: Clarification of the operating results of company and its subsidiaries for the year ended December 31, 2017 To: Boards and Managements The Stock Exchange of Thailand K.C
for the first quarter ending 31 March 2018, which has already been examined by the Company’s auditor, the results can be summarized as follows; Performance Highlights for Q1/2018 Net Profit attributed
November 12, 2004 1/4 (-Translation-) No: SN. 029/2018 May 14, 2018 Subject: Clarification of Operating Results and Financial Status the six-month period ended March 31, 2018 Attention: President The
%, in line with the financial results of the Company and its subsidiaries in Thailand, as a subsidiary in Lao PDR gets a tax exempt. Statement of Financial Position March 31, 2018 December 31, 2017 Change
MARCH 31, 2018 1. Analysis of operation results for the fir st quarter of 2018 in compar ison with those for the same quar ter of 2017 (from the consolidated financial statements) Items First quarter of
/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
Ocean Commerce Limited ( Company) No. 4/2018 held on August 8, 2018 , has approved the financial statements and results of operations of the Company. For the ended June 30, 2018 which was audited by the